5.98 USD
↘ 0.06 (0.99%)AT CLOSE (03:59 PM EST)
Eikon Therapeutics, Inc. Common Stock
EIKNNASDAQ • USD
5.98
↗ 0.00 (0.00%)
POST MARKET (AS OF 07:59 PM EST)
Post Market
AS OF 07:59 PM EST
5.98
↗ 0.00 (0.00%)
Market: CLOSED
EIKN is currently priced at $5.98. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, EIKN appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 13, 2026.
Open?$6.06
High?$6.10
Low?$5.58
Prev. Close?$6.04
Volume?294.0K
Avg. Volume?545.4K
VWAP?$5.87
Rel. Volume?0.54x
Bid / Ask
Bid?$5.80 × 100
Ask?$6.83 × 100
Spread?$1.03
Midpoint?$6.31
Valuation & Ratios
Market Cap?324.0M
Shares Out?N/A
Float?31.2M
Float %?57.7%
P/E Ratio?N/A
P/B Ratio?0.84
EPS?-$6.06
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.
Employees
384
Market Cap
324.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2026-02-05
Address
230 HARRIET TUBMAN WAY
MILLBRAE, CA 94030
Phone: 341-777-0566
MILLBRAE, CA 94030
Phone: 341-777-0566
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestVery High
Short % of Float?17.73%High
Short Interest?5.5M
Days to Cover?10.5
Free Float31.2M
Avg Daily Volume529.0K
Settlement Date2026-10-30
Financial Health
Current Ratio?7.21Strong
Quick Ratio?7.21Strong
Cash Ratio?1.49Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.84CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.7CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-85.5%WEAK▾
S&P3
ROA?-46.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-287018000
Enterprise Value?$225.6M
Fundamentals ratios updated end of day